Taken together, these results indicate that the down-regulation of miR-30c is associated with both eccentric and concentric cardiac hypertrophy, and the decrease of miR-30c may cause accumulation of CTGF, contributing to disease progression by pro-fibrotic effect. Here, CCN2 is linked to cardiac hypertrophy.